UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to ____________ Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Delaware ...

Streamline Health Solutions Inc. (NASDAQ:STRM) Q2 2023 Earnings Conference Call September 14, 2023 9:00 AM ET Company Participants Jacob Goldberger - Director, Investor Relations and FP&A Tee Green - Chief Executive Officer Ben Stilwill - President Tom Gibson - Senior Vice President and Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Aaron Wukmir - Lake Street Capital Operator Greetings. Welcome to the Streamline Health Solutions Second Quarter 2023 Earnings Conference Call. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to ____________ Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Delaware 31 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to ____________ Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Delaware 3 ...

Streamline Health Solutions Inc. (NASDAQ:STRM) Q1 2023 Earnings Conference Call June 13, 2023 9:00 AM ET Company Participants Tee Green - Chief Executive Officer Ben Stilwill - President Tom Gibson - Senior Vice President, Chief Financial Officer Jacob Goldberger - Director, Investor Relations and FP&A Conference Call Participants Matt Hewitt - Craig Hallum Capital Brooks O’Neil - Lake Street Capital Operator Greetings. Welcome to Streamline Health Solutions’ first quarter fiscal 2023 earnings conference ca ...

Streamline Health Solutions, Inc. (NASDAQ:STRM) Q4 2022 Earnings Conference Call April 27, 2023 9:00 AM ET Company Participants Jacob Goldberger - Director, Investor Relations and FP&A Wyche Green - Chief Executive Officer Ben Stilwill - President Tom Gibson - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Brooks O'Neil - Lake Street Capital Markets Operator Greetings and welcome to the Streamline Health Fourth Quarter and Fiscal Year 2022 Earnings Conference C ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________to___________ Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Delaware 31-145541 ...

Financial Data and Key Metrics Changes - For the third quarter of fiscal 2022, total GAAP revenues were $6.2 million, a 13% increase compared to the same period last year [25] - For the nine months ended October 31, 2022, total GAAP revenue increased 60% to $18.1 million, with $5.8 million of the revenue growth attributable to the acquisition of Avelead [25] - SaaS revenue grew by $0.4 million or 14% in the third quarter compared to the previous year, and for the nine months, SaaS revenues increased by $3.8 million or 72% [25][26] - The net loss for the third quarter was $3.1 million, an improvement from a net loss of $4.3 million in the same quarter of the previous year [29] - Adjusted EBITDA for the third quarter was a loss of $1.2 million, compared to a loss of $0.3 million in the prior year [30] Business Line Data and Key Metrics Changes - Bookings for the nine months ended October 31, 2022, totaled $15.9 million, with $14.1 million from SaaS products [8] - Booked SaaS ACV as of October 31 was $14.9 million, up from $10.3 million as of January 31, 2022 [9] - The company expects to achieve $17 million of booked SaaS ACV by the end of fiscal 2022 [20] Market Data and Key Metrics Changes - The company is facing macro headwinds affecting hospital clients, including staffing shortages and IT project backlogs, which hinder the conversion of new bookings to revenue [8][26] - As of November 30, 2022, there was $4.5 million of annualized contract value that was unimplemented, indicating a backlog due to IT resource constraints [26][36] Company Strategy and Development Direction - The company announced a strategic alignment of its business to enhance growth and profitability, expecting to realize $3 million in annualized cost savings [11][12] - The focus remains on improving the back-end architecture of the Avelead suite and enhancing the effectiveness of the sales force [16][17] - The company aims to deliver improved net revenue to hospital clients through automated solutions, which are increasingly critical in the current environment [12] Management's Comments on Operating Environment and Future Outlook - Management noted that the macro environment for hospital clients has resulted in higher demand for their products and services [12] - The company is confident in achieving positive adjusted EBITDA less capitalized software development, with a clear path to cash generation [24][37] - Management expects revenue growth to accelerate in fiscal 2023 as contracts are implemented [26] Other Important Information - The company had $11.7 million in cash on hand as of October 31, 2022, following a registered direct offering that raised approximately $8.3 million [10][31] - The company expanded its relationship with Bridge Bank to include a $2 million non-formula line of credit [11][35] Q&A Session Summary Question: Clarification on breakeven at $17 million booked SaaS revenue - Management clarified that the $17 million of booked SaaS revenue must be fully implemented to achieve breakeven, and they expect full implementation by Q2 or Q3 of 2023 [41][43] Question: Challenges in contract generation vs. implementation - Management indicated that the bigger challenge currently is the implementation side due to IT resource constraints in hospitals, which affects the timing of contract implementations [44][45] Question: Status with major electronic medical records vendors - Management confirmed a strong partnership with Cerner and ongoing efforts to work with Epic, noting that referrals from existing Epic customers are crucial for gaining new clients [48] Question: Completeness of the solution combining flagship products - Management stated that while they have components of the revenue cycle, they are focused on a niche market and are open to future opportunities for expansion [48]

| --- | --- | --- | |-------------------------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | Third Quarter 2022 Earnings Presentation Nasdaq: STRM | | | Streamline Health (Nasdaq: STRM) 2 Disclosure Statement SAFE HARBOR STATEMENT: FORWARD-LOOKING DISCLOSURE This presentation contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, based on current management expectations. Because forward-looking statements rela ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to ____________ Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Delaware ...